These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 22622811
1. Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer. Sandberg ME, Hartman M, Klevebring D, Eloranta S, Ploner A, Hall P, Czene K. Breast Cancer Res Treat; 2012 Jul; 134(2):793-800. PubMed ID: 22622811 [Abstract] [Full Text] [Related]
2. Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries. Mezencev R, Švajdler M. Breast Cancer; 2017 May; 24(3):400-410. PubMed ID: 27502779 [Abstract] [Full Text] [Related]
5. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy. Alkner S, Ehinger A, Bendahl PO, Rydén L, Fernö M. Eur J Cancer; 2015 Nov; 51(16):2304-13. PubMed ID: 26243193 [Abstract] [Full Text] [Related]
9. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses. Vichapat V, Garmo H, Holmberg L, Fentiman IS, Tutt A, Gillett C, Lüchtenborg M. Breast Cancer Res Treat; 2011 Nov; 130(2):609-18. PubMed ID: 21671018 [Abstract] [Full Text] [Related]
10. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Schaapveld M, Visser O, Louwman WJ, Willemse PH, de Vries EG, van der Graaf WT, Otter R, Coebergh JW, van Leeuwen FE. Breast Cancer Res Treat; 2008 Jul; 110(1):189-97. PubMed ID: 17687645 [Abstract] [Full Text] [Related]
11. Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen. Arpino G, Weiss HL, Clark GM, Hilsenbeck SG, Osborne CK. J Clin Oncol; 2005 Jul 20; 23(21):4687-94. PubMed ID: 15837971 [Abstract] [Full Text] [Related]
12. Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen. Khoshnoud MR, Fornander T, Johansson H, Rutqvist LE. Breast Cancer Res Treat; 2008 Jan 20; 107(1):71-8. PubMed ID: 18043896 [Abstract] [Full Text] [Related]
13. Bilateral breast cancer. Gogas J, Markopoulos C, Skandalakis P, Gogas H. Am Surg; 1993 Nov 20; 59(11):733-5. PubMed ID: 8239195 [Abstract] [Full Text] [Related]
14. Pattern of hormone receptor status of secondary contralateral breast cancers in patients receiving adjuvant tamoxifen. Bachleitner-Hofmann T, Pichler-Gebhard B, Rudas M, Gnant M, Taucher S, Kandioler D, Janschek E, Dubsky P, Roka S, Sporn E, Jakesz R. Clin Cancer Res; 2002 Nov 20; 8(11):3427-32. PubMed ID: 12429630 [Abstract] [Full Text] [Related]